A Pradalier, J Dry, B Loisy, V Meininger, E Vicaut, C Mirabaud, M Levy. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultClinical Trials as TopicDihydroergotamine/adverse effectsDihydroergotamine/therapeutic useDouble-Blind MethodDrug EvaluationHumansIndoles/therapeutic useIndoramin/adverse effectsIndoramin/therapeutic useMiddle AgedMigraine Disorders/prevention & controlTime Factors
Substances: See more » IndolesIndoraminDihydroergotamine
Year: 1988 PMID: 3055407
Source DB: PubMed Journal: Therapie ISSN: 0040-5957 Impact factor: 2.070